XML 53 R42.htm IDEA: XBRL DOCUMENT v3.21.2
License and Collaboration Agreements - Additional Information (Details) - USD ($)
 1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2019
Research and License Agreements            
Revenue   $ 86,560 $ 1,000,000 $ 1,142,142 $ 10,000,000  
Apollomics, Inc.            
Research and License Agreements            
Up-front payment received           $ 9,000,000.0
Milestones based on achievement of certain clinical and regulatory events           75,000,000.0
Milestone payment upon achievement of specified net sales thresholds for all licensed products           $ 105,000,000.0
Milestone revenue recognized based on achievement of certain clinical and regulatory events $ 1,000,000.0   $ 1,000,000.0      
Revenue       $ 1,100,000    
Apollomics, Inc. | Maximum            
Research and License Agreements            
Tiered percentage of annual net sales           15.00%